DrugPatentWatch Database Preview
Dexamethasone - Generic Drug Details
What are the generic sources for dexamethasone and what is the scope of patent protection?
Dexamethasone
is the generic ingredient in thirty-three branded drugs marketed by Allergan Herbert, Merck, West-ward Pharms Int, Alpharma Us Pharms, Lannett Co Inc, Lyne, Sti Pharma Llc, Wockhardt Bio Ag, Aspen Global Inc, Allergan, Ocular Therapeutix, Watson Labs, Novartis Pharms Corp, Eyepoint Pharms, Ani Pharms Inc, ECR, Fera Pharms Llc, Heritage Pharma, Impax Labs, Larken Labs Inc, Par Pharm, Phoenix Labs Ny, Pvt Form, Roxane, Sun Pharm Industries, Upsher Smith, Whiteworth Town Plsn, Xspire Pharma, Solvay, Watson Labs Teva, Ucb Inc, Cent Pharms, Abraxis Pharm, Fresenius Kabi Usa, Akorn, Amneal Pharms Co, Aurobindo Pharma Ltd, Bel Mar, Dell Labs, Dr Reddys, Intl Medication, Luitpold, Lyphomed, Mylan Labs Ltd, Somerset Theraps Llc, Teva Parenteral, Wyeth Ayerst, Pharmafair, Alcon, Sola Barnes Hind, Bausch And Lomb, Sandoz Inc, Alcon Pharms Ltd, Novartis, and Perrigo Co Tennessee, and is included in one hundred and thirty NDAs. There are twenty-seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.Dexamethasone has two hundred and one patent family members in thirty countries.
There are thirty-nine drug master file entries for dexamethasone. Twenty-eight suppliers are listed for this compound.
Summary for dexamethasone
| International Patents: | 201 |
| US Patents: | 27 |
| Tradenames: | 33 |
| Applicants: | 55 |
| NDAs: | 130 |
| Drug Master File Entries: | 39 |
| Suppliers / Packagers: | 28 |
| Bulk Api Vendors: | 98 |
| Clinical Trials: | 2,393 |
| Patent Applications: | 7,284 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price trends for dexamethasone |
| Drug Sales Revenues: | Drug sales revenues for dexamethasone |
| DailyMed Link: | dexamethasone at DailyMed |
Recent Clinical Trials for dexamethasone
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia | Phase 2 |
| Heron Therapeutics | Phase 2 |
| Yale University | N/A |
Pharmacology for dexamethasone
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for dexamethasone
Synonyms for dexamethasone
| .delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol |
| .gamma.corten |
| (11|A,16|A)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione; 9|A-Fluoro-16|A-methyl-11|A,17|A,21-trihydroxy-1,4-pregnadiene-3,20-dione; 9|A-Fluoro-16|A-methylprednisolone; Prednisolone F |
| (11beta,16alpha)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione |
| (11beta,16alpha)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione labeled with tritium |
| (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one |
| (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadeca-3,6-dien-5-one |
| (1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0(2),.0(1)(1),(1)]heptadeca-3,6-dien-5-one |
| (2S,10S,11S,15S,17S,1R,13R,14R)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)- 2,13,15-trimethyltetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-5-one |
| (3H)-Dexamethasone |
| (8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one |
| (8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]ph |
| (8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one |
| [3H]-dexamethasone |
| [3H]dexamethasone |
| 064D136 |
| 1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone |
| 1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone |
| 1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone |
| 1050677-47-8 |
| 137098-19-2 |
| 16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione |
| 16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol |
| 16-alpha-Methyl-9-alpha-fluoro-1,4-pregnadiene-11-beta,17-alpha,21-triol-3,20-dione |
| 16-alpha-Methyl-9-alpha-fluoro-11-beta,17-alpha,21-trihydroxypregna-1,4-diene-3,20-dione |
| 16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone |
| 16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone |
| 16-alpha-Methyl-9-alpha-fluoroprednisolone |
| 16.alpha.-Methyl-9.alpha.-fluoro-.delta.(sup1)-hydrocortisone |
| 16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol |
| 16.alpha.-Methyl-9.alpha.-fluoro-11.beta.-17.alpha.-21-trihydroxypregna-1,20-dione |
| 16.alpha.-Methyl-9.alpha.-fluoroprednisolone |
| 16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol |
| 16alpha -Methyl-9alpha -fluoroprednisolone |
| 16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol |
| 16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone |
| 16alpha-Methyl-9alpha-fluoroprednisolone |
| 1793-EP2269977A2 |
| 1793-EP2269989A1 |
| 1793-EP2269990A1 |
| 1793-EP2270008A1 |
| 1793-EP2270014A1 |
| 1793-EP2270018A1 |
| 1793-EP2272832A1 |
| 1793-EP2275420A1 |
| 1793-EP2277565A2 |
| 1793-EP2277566A2 |
| 1793-EP2277567A1 |
| 1793-EP2277568A2 |
| 1793-EP2277569A2 |
| 1793-EP2277570A2 |
| 1793-EP2277861A1 |
| 1793-EP2277865A1 |
| 1793-EP2277876A1 |
| 1793-EP2279741A2 |
| 1793-EP2281563A1 |
| 1793-EP2289894A2 |
| 1793-EP2292227A2 |
| 1793-EP2292280A1 |
| 1793-EP2292589A1 |
| 1793-EP2292614A1 |
| 1793-EP2292617A1 |
| 1793-EP2295055A2 |
| 1793-EP2295402A2 |
| 1793-EP2295409A1 |
| 1793-EP2295412A1 |
| 1793-EP2295413A1 |
| 1793-EP2295416A2 |
| 1793-EP2298731A1 |
| 1793-EP2298743A1 |
| 1793-EP2298748A2 |
| 1793-EP2298764A1 |
| 1793-EP2298765A1 |
| 1793-EP2298772A1 |
| 1793-EP2298778A1 |
| 1793-EP2298779A1 |
| 1793-EP2298780A1 |
| 1793-EP2305248A1 |
| 1793-EP2305642A2 |
| 1793-EP2305663A1 |
| 1793-EP2305689A1 |
| 1793-EP2308562A2 |
| 1793-EP2308812A2 |
| 1793-EP2308833A2 |
| 1793-EP2308839A1 |
| 1793-EP2308880A1 |
| 1793-EP2311453A1 |
| 1793-EP2314585A1 |
| 1793-EP2314590A1 |
| 1793-EP2316459A1 |
| 1793-EP2316832A1 |
| 1793-EP2316833A1 |
| 1793-EP2316834A1 |
| 1793-EP2371811A2 |
| 1p93 |
| 23495-06-9 |
| 4-alpha-Fluoro-16-alpha-methyl-11-beta,17,21-trihydroxypregna-1,4-diene-3,20-dione |
| 4.alpha.-Fluoro-16.alpha.-methyl-11.beta.-17,4-diene-3,20-dione |
| 50-02-2 |
| 7S5I7G3JQL |
| 8054-59-9 |
| 9-alpha-Fluoro-16-alpha-methyl-1,4-pregnadiene-11-beta,17-alpha,21-triol-3,20-dione |
| 9-alpha-Fluoro-16-alpha-methylprednisolone |
| 9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione |
| 9-Fluoro-11.beta.,21-trihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione |
| 9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione |
| 9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione |
| 9-Fluoro-16-methylprednisolone |
| 9-fluoro-16alpha-methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione |
| 9.alpha.-Fluoro-11.beta.-17.alpha.- 21-trihydroxy-16.alpha.-methylpregna-1,20-dione |
| 9.alpha.-Fluoro-16.alpha.-methyl-1,20-dione |
| 9.alpha.-Fluoro-16.alpha.-methyl-11.beta.,21.beta.-trihydroxy-pregna-1,4-diene-3,20-dione |
| 9.alpha.-Fluoro-16.alpha.-methylprednisolone |
| 906362-70-7 |
| 906422-84-2 |
| 9a-Fluoro-11b,17a,21-trihydroxy-16a-methylpregna-1,4-diene-3,20-dione |
| 9A-FLUORO-16BETA-METHYLPREDNISOLONE |
| 9alpha -Fluoro-16alpha -methylprednisolone |
| 9alpha-Fluoro-16alpha-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione |
| 9alpha-fluoro-16alpha-methyl-Prednisolone |
| 9alpha-Fluoro-16alpha-methylprednisolone |
| AB0072035 |
| AB00918428_10 |
| AB00918428-05 |
| AB00918428-08 |
| AB00918428-09 |
| AB1009273 |
| AC-11056 |
| AC1L1L1H |
| AC1Q29DM |
| ACN-036253 |
| Adexone |
| Aeroseb-D |
| Aeroseb-Dex |
| AI3-50934 |
| AJ-46415 |
| Ak Dex Oph Otic Soln 0.1% |
| AKOS005259009 |
| AKOS015895509 |
| alpha -Fluoro-16-alpha -methylcortisol |
| Anaflogistico |
| Aphtasolon |
| Aphthasolone |
| Apo-dexamethasone |
| ARONIS27003 |
| Auxiron |
| Azimycin (Veterinary) |
| Azium |
| Azium (Veterinary) |
| BC201625 |
| BDBM18207 |
| BIDD:ER0494 |
| BIDD:PXR0060 |
| Bisu DS |
| BRD-K38775274-001-02-3 |
| BRD-K38775274-001-06-4 |
| BSPBio_000995 |
| C15643 |
| C22H29FO5 |
| Calonat |
| CAS-50-02-2 |
| CCRIS 7067 |
| CHEBI:41879 |
| CHEMBL384467 |
| Corson |
| Corsone |
| Cortisumman |
| CS-1505 |
| D00292 |
| DB01234 |
| Decacort |
| Decacortin |
| Decaderm |
| Decadron |
| Decadron (TN) |
| Decadron phosphate, Decdan, Dexacort, |
| Decadron Tablets, Elixir |
| Decagel |
| Decaject |
| Decaject-L.A. |
| Decalix |
| Decameth |
| Decasone |
| Decaspray |
| Dectancyl |
| Dekacort |
| delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol |
| delta1-9alpha-Fluoro-16alpha-methylcortisol |
| Deltafluorene |
| Dergramin |
| Deronil |
| Desadrene |
| Desametasone |
| Desametasone [DCIT] |
| Desamethasone |
| Desameton |
| Deseronil |
| Dex-ide |
| Dexa Mamallet |
| Dexa-Cortidelt |
| Dexa-Cortisyl |
| Dexa-Mamallet |
| Dexa-Scheroson |
| Dexa-sine |
| Dexacen-4 |
| Dexacidin |
| Dexacort |
| Dexacortal |
| Dexacortin |
| Dexadeltone |
| Dexafarma |
| Dexair |
| Dexalona |
| Dexaltin |
| Dexametasona |
| Dexametasona [INN-Spanish] |
| Dexametasone |
| Dexameth |
| Dexamethansone |
| Dexamethasone Cyclodextrin complex |
| Dexamethasone (DHAP) |
| Dexamethasone (JP17/USP/INN) |
| dexamethasone (tetramethyl-rhodamine conjugated ) |
| Dexamethasone [INN:BAN:JAN] |
| Dexamethasone [USP:INN:BAN:JAN] |
| Dexamethasone 1.0 mg/ml in Methanol |
| Dexamethasone alcohol |
| Dexamethasone Base |
| Dexamethasone for peak identification, European Pharmacopoeia (EP) Reference Standard |
| Dexamethasone for system suitability, European Pharmacopoeia (EP) Reference Standard |
| Dexamethasone Intensol |
| Dexamethasone solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material |
| Dexamethasone-omega |
| Dexamethasone, >=97.0% (HPLC) |
| Dexamethasone, >=98% (HPLC), powder |
| Dexamethasone, 96% |
| Dexamethasone, British Pharmacopoeia (BP) Assay Standard |
| Dexamethasone, European Pharmacopoeia (EP) Reference Standard |
| Dexamethasone, meets USP testing specifications |
| Dexamethasone, Pharmaceutical Secondary Standard; Certified Reference Material |
| Dexamethasone, powder, BioReagent, suitable for cell culture, >=97% |
| Dexamethasone, powder, gamma-irradiated, BioXtra, suitable for cell culture, >=80% (HPLC) |
| Dexamethasone, tested according to Ph.Eur. |
| Dexamethasone, topical |
| Dexamethasone, United States Pharmacopeia (USP) Reference Standard |
| Dexamethasone, VETRANAL(TM), analytical standard |
| Dexamethasonum |
| Dexamethasonum [INN-Latin] |
| Dexamethazone |
| Dexamonozon |
| Dexapolcort |
| Dexapos |
| Dexaprol |
| DexaSite |
| Dexason |
| Dexasone |
| Dexasone 0.5mg |
| Dexasone 0.75mg |
| Dexasone 4mg |
| Dexinolon |
| Dexinoral |
| Dexone |
| Dexone 0.5 |
| Dexone 0.75 |
| Dexone 1.5 |
| Dexone 4 |
| Dexonium |
| Dexpak |
| Dextelan |
| Dextenza |
| Dezone |
| Dinormon |
| DSSTox_CID_384 |
| DSSTox_GSID_20384 |
| DSSTox_RID_75557 |
| DTXSID3020384 |
| DXM |
| DXM [Steroid] |
| Dxms |
| EINECS 200-003-9 |
| EN300-52607 |
| Fluormethylprednisolone |
| Fluormone |
| Fluorocort |
| Fortecortin |
| FT-0080377 |
| FT-0601576 |
| FT-0603100 |
| Gammacorten |
| GTPL2768 |
| GTPL3447 |
| Hexadecadrol |
| Hexadrol |
| Hexadrol Elixir |
| Hexadrol Tablets |
| Hl-dex |
| HMS1792A17 |
| HMS1990A17 |
| HMS2089N13 |
| HMS2235F08 |
| HMS3039L11 |
| HMS3259N11 |
| HMS3403A17 |
| HSDB 3053 |
| HY-14648 |
| I06-1196 |
| IBI-10090 |
| IontoDex |
| Isopto-Dex |
| ISV-305 |
| J10029 |
| KS-000048I3 |
| KS-1451 |
| Lokalison F |
| Loverine |
| LS-7300 |
| Luxazone |
| Maxidex |
| Maxidex Ont 0.1% |
| Maxidex Sus 0.1% |
| Maxitrol |
| MCULE-4773827191 |
| Mediamethasone |
| Methylfluorprednisolone |
| Mexidex |
| MFCD00064136 |
| Millicorten |
| MK 125 |
| MLS001055412 |
| MLS001332507 |
| MLS001332508 |
| MolMap_000018 |
| MolPort-003-846-433 |
| Mymethasone |
| Naquasone (Veterinary) |
| NC00645 |
| NCGC00091019-01 |
| NCGC00091019-02 |
| NCGC00091019-03 |
| NCGC00091019-04 |
| NCGC00091019-05 |
| NCGC00091019-06 |
| NCGC00091019-07 |
| NCGC00091019-08 |
| NCGC00257676-01 |
| NCI60_003067 |
| Neomycin and polymyxin b sulphates and dexamethasone |
| NSC 34521 |
| NSC-34521 |
| NSC34521 |
| Ocu-trol |
| Oradexon |
| Osurdex |
| OTO-104 |
| Ozurdex |
| Pet Derm III |
| Pet-Derm Iii |
| PHL-dexamethasone |
| PMS Dexamethasone Elixir 0.5mg/5ml |
| PMS-dexamethasone |
| Policort |
| Posurdex |
| Prednisolon F |
| Prednisolone F |
| Prednisolone, 9.alpha.-fluoro-16.alpha.-methyl- |
| Prednisolone, 9alpha -fluoro-16alpha -methyl- |
| Prednisolone, 9alpha-fluoro-16alpha-methyl- |
| Pregna-1,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11.beta.,16.alpha.)- |
| Pregna-1,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.alpha.-methyl- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11.beta.,16.alpha.)- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11beta,16alpha)- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, labeled with tritium, (11beta,16alpha)- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11alpha -methyl- |
| Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16alpha-methyl- |
| Prodex |
| Q-200939 |
| s1322 |
| Sandoz Dexamethasone |
| SC-16127 |
| SCHEMBL3774 |
| SGCUT00126 |
| SK-Dexamethasone |
| SMP1_000092 |
| SMR000857119 |
| SMR001227192 |
| Spectrum5_002019 |
| Spoloven |
| ST24046431 |
| ST50307091 |
| Sunia Sol D |
| Superprednol |
| sustained-release dexamethasone |
| TL8003317 |
| to_000038 |
| Tox21_200122 |
| Tresaderm (Veterinary) |
| Turbinaire |
| UNII-7S5I7G3JQL |
| UREBDLICKHMUKA-CXSFZGCWSA-N |
| Visumetazone |
| W-5058 |
| WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1 |
| Z802671480 |
| ZINC3875332 |
US Patents and Regulatory Information for dexamethasone
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | DEXONE 0.5 | dexamethasone | TABLET;ORAL | 084991-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Pricing | See Pricing | See Pricing | ||||
| Allergan | OZURDEX | dexamethasone | IMPLANT;INTRAVITREAL | 022315-001 | Jun 17, 2009 | RX | Yes | Yes | See Pricing | See Pricing | Y | See Pricing | |||
| Novartis Pharms Corp | TOBRADEX ST | dexamethasone; tobramycin | SUSPENSION/DROPS;OPHTHALMIC | 050818-001 | Feb 13, 2009 | RX | Yes | Yes | See Pricing | See Pricing | Y | See Pricing | |||
| Impax Labs | DEXAMETHASONE | dexamethasone | TABLET;ORAL | 085376-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | See Pricing | See Pricing | See Pricing | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for dexamethasone
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Taiwan | 200635565 | See Pricing |
| European Patent Office | 2799064 | See Pricing |
| Canada | 2429998 | See Pricing |
| Portugal | 1296645 | See Pricing |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for dexamethasone
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 1581193 | 122012000081 | Germany | See Pricing | PRODUCT NAME: DEXAMETHASON; REGISTRATION NO/DATE: EU/1/10/638/001 20100727 |
| 1429780 | SPC/GB12/058 | United Kingdom | See Pricing | PRODUCT NAME: A COMBINATION OF CIPROFLOXACIN AND DEXAMETHASONE, PREFERABLY CIPROFLOXACIN HYDROCHLORIDE AND DEXAMETHASONE; REGISTERED: DK DE/11/3337/001/DC 20120808; UK PL000649/0381-0001 20121003 |
| 1429780 | 13C0012 | France | See Pricing | PRODUCT NAME: COMBINAISON DE CIPROFLOXACINE ET DE DEXAMETHASONE, EN PARTICULIER DE CHLORHYDRATE DE CIPROFLOXACINE ET DE DEXAMETHASONE; NAT. REGISTRATION NO/DATE: NL 41308 20121214; FIRST REGISTRATION: 48976 20120808 |
| 1581193 | C300552 | Netherlands | See Pricing | PRODUCT NAME: VOOR GEBRUIK IN EEN WERKWIJZE VOOR DE BEHANDELING VAN MACULAIR OEDEEM; REG. NO/DATE: EU/1/10/638/001 20100727 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2019 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
Major Patent Expirations 2019 - 2020
NCE-1 Generic Application Dates 2019 - 2020
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
Major Patent Expirations 2019 - 2020
NCE-1 Generic Application Dates 2019 - 2020
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2019, www.DrugPatentWatch.com.